Ibandronate Sodium 138926-19-9
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- 138926-19-9, ibandronate sodium
- Category
- Pharmaceutical Intermediates
Hangzhou Eastbiopharm Co., Ltd.
- Country / Year Established
-
China
/
- Business type
- Others
- Verified Certificate
-
13
| Product name | Ibandronate Sodium 138926-19-9 | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | 138926-19-9 , ibandronate sodium | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Name: Ibandronate Sodium
CAS No.: 138926-19-9
Specifications:
CAS NO.: 138926-19-9
Chemical name:1-Hydroxy-3-(methylpentylamino)propylidene bisphosphonate monosodium monohydrate
Properties: white crystal powder
Molecular formula: C9H22O7NP2Na H2O
Molecular weight:359.17
Assay: 99.0% (by HPLC)
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Yuwei Wang
- Address
- No15A12 Room, No39 Yile Road, Hangzhou,China,310012
- Product Category
- Pharmaceutical Intermediates
- No. of Total Employees
- 51-100
- Company introduction
-
Reliable premium supplier and R&D partner for API, Fine Chemicals, Intermediates and New Molecules.
Eastbiopharm is one of the top competitive pharmaceutical suppliers in China which greatly integrates manufacturing, R&D, international trade, technical consulting & service, Drug registration and technology transfer. We are always focusing on the goal of providing R&D, custom synthesis, contract production, Export & import, sourcing of premium APIs, Intermediates, functional food additives, Fine Chemicals, veterinary drugs and New Molecules. “Honesty and worthy, Mutual benefit” as the tenet of the enterprise We are striving to gain mutual benefits through Marketing information, technology research, Production, Marketing, R&D of new drugs & generic drugs.
[benfotiamine 22457-89-2],[lopinavir intermediates 156732-13-7, 192725-50-1], [Phloroglucinol 108-73-6],[Phloroglucinol dihydrate 6099-90-7],[thiomorpholine 123-90-0], [capecitabine 154361-50-9], [N-methyltaurine sodium 4316-74-9]， [CBZ-cyclohexyl-L-glycine 69901-75-3], [thiomorpholine-1,1-dioxide 39093-93-1], [3-pyridylacetic acid HCL 6419-36-9], [Diethyl pyrocarbonate (DEPC) 1609-47-8], [3-Aminopropane sulfonic acid 3687-18-1], [3,5-bis(trifluoromethyl)acetophenone 30071-93-3], [3,5-bis(trifluoromethyl)benzoic acid 725-89-3], [Phenylboronic acid 98-80-6], [sodium(+)-10-camphorsulfonate 21791-94-6], [bethanechol 590-63-6], [butaphosphon 17316-67-5], [Ibandronate sodium 138926-19-9], [Synephrine HCL 5985-28-4], [Chrysin 480-40-0], [Formononetin 485-72-3], [5,7-dihydrox-4`-methoxyisoflavone 491-80-5], [Clopidogrel 113665-84-2, 141109-19-5], [ Cilastatin 82009-34-5], [Lansoprazole 103577-45-3], [melatonine 73-31-4], [Daidzein 486-66-8], [ Tetrahydrofurfuryl bromide 1192-30-9], [Anastrozole 120511-73-1 ] [ 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride 2328-12-3], [ Evodiamine 518-17-2], [ Anthracene-9-carboxylic acid 723-62-6], [Tetrahydrofurfuryl bromide 1192-30-9].
- Main Markets
-
India
Iran
South Korea
Taiwan
U.S.A
- Main Product
